Researchers at the University of Alabama, Birmingham Comprehensive Cancer Center received a $5.1 million support grant from the NIH this year. The abstract for the grant on NIH RePORTER says of the Comprehensive Cancer Center:
Science Market Update
Science researchers at the University of Alabama at Birmingham recently received a $3 million grant that will be distributed over five years to join the Women’s Interagency HIV study (WIHS). Michael Saag, M.D. is the study’s principal investigator, and Mirjam-Collete Kempf, Ph.D., M.P.H. is the co-principal investigator. The researchers will begin recruiting women for the study this coming October.
The National Eye Institute, an NIH agency dedicated to vision research, recently announced the winners of their Challenge to Identify Audacious Goals in Vision Research and Blindness Rehabilitation, or the Audacious Goals Challenge for short. The competition was open to professionals and members of the public and called upon them to think big and bold about vision research goals for the next decades. The prize money was nominal ($3,000) but included an invitation and travel money to attend and present their ideas at the NEI Audacious Goals Development Meeting in Maryland later this month. The real prize, of course, was the opportunity to help set research and funding goals for the next 10-12 years. Of the 500 or so proposals submitted, 10 visionaries were selected as winners.
Tags: University of Michigan, 2014, CA, Harvard University, Midwest, 2013, Northeast, university of utah, Washington University, Missouri, WashU, UUtah, St. Louis Bioresearch Product Faire Event, Oregon Health and Science University, Northwest, crowdsourcing, Vision Sciences Research, National Eye Institute (NEI), Blindness Rehabilitation, Southwest, University of Alabama, Southern, UT, Ann Arbor, Boston, BioResearch Product Faire Event, Funding, MI, MA, NIH, Harvard, OR, Salt Lake City, Birmingham, AL, UCSB, Santa Barbara, OHSU, Portland, UMich, UC Santa Barbara, Rehabilitation
The University of Alabama is an unexpected standout in the science research marketplace. This campus ranks among the top in the nation, flanking closely with the top NIH funded universities, and yet there is surprisingly little sales rep traffic on campus.
The University of Alabama at Birmingham has been awarded a $7 million research grant to continue its leadership in pioneering clinical trials in the treatment of neurofibromatosis 1 and 2 and schwannomatosis, all rare genetic diseases. According to the Birmingham Business Journal, the circumstances of these diseases lead to non-cancerous tumors forming on the nerves and potentially causing blindness, hearing loss, learning disabilities, pain or deformity.
Catastrophe has a way of catalyzing need and resources. The 2010 BP oil spill in the Gulf of Mexico has made University of Alabama (UAB) scientists' expertise in the biomarine environment off their coast particularly valuable. BP has pledge up to $500 Million to study the effects of the spill, and some of that funding is making its way to biomarine research projects at UA-Birmingham through Alabama's Marine Environmental Science Consortium (MESC) and the larger Gulf Research Initiative Open Research Program. The MESC has distributed $5 Million in Rapid Response Funds already, and 16 UAB researchers have received $308,344 in grants to fund pilot projects identified by and applied for at the UAB Gulf Oil Spill Summit last fall.